Published in J Neural Transm (Vienna) on July 26, 2012
Challenges in understanding psychiatric disorders and developing therapeutics: a role for zebrafish. Dis Model Mech (2015) 0.81
The fluorescent toolbox for assessing protein location and function. Science (2006) 14.02
The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry (2007) 14.02
Microscopy and its focal switch. Nat Methods (2009) 6.37
Development and use of fluorescent protein markers in living cells. Science (2003) 5.47
Light microscopy techniques for live cell imaging. Science (2003) 4.77
Imagining imaging's future. Nat Rev Mol Cell Biol (2003) 3.24
Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics (1992) 2.55
D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol (2007) 2.28
The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J Biol Chem (2003) 2.14
European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry (2010) 1.92
Tracking in cell and developmental biology. Semin Cell Dev Biol (2009) 1.77
The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet (2005) 1.70
The nature and heritability of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am (2001) 1.50
Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. Am J Hum Genet (2008) 1.50
Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J Clin Invest (1997) 1.48
Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol Ther (2008) 1.44
Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse. Neuropsychopharmacology (2006) 1.39
Methylphenidate: its pharmacology and uses. Mayo Clin Proc (2000) 1.39
Modelling the molecular mechanisms of synaptic plasticity using systems biology approaches. Nat Rev Neurosci (2010) 1.32
Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. J Neurosci (2010) 1.19
A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Brain Res Mol Brain Res (1992) 1.18
Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. Anal Chem (2002) 1.12
A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study. J Child Adolesc Psychopharmacol (2006) 1.10
From micro to nano: recent advances in high-resolution microscopy. Curr Opin Biotechnol (2005) 1.07
The functional role of P-glycoprotein in the blood-brain barrier. J Pharm Sci (1997) 1.07
Impedance measurement for real time detection of neuronal cell death. J Neurosci Methods (2011) 1.04
Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci (2007) 1.04
Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD. Neuropharmacology (2009) 1.01
Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood. Neurosci Biobehav Rev (2011) 1.00
Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors. Neuropsychopharmacology (2006) 0.98
Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? J Clin Psychopharmacol (2008) 0.95
Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations. Br J Pharmacol (2010) 0.95
DNA methylation profiling using live-cell imaging. Methods (2010) 0.90
Annual Research Review: The promise of stem cell research for neuropsychiatric disorders. J Child Psychol Psychiatry (2011) 0.89
Synaptic vesicle recycling is enhanced by torsinA that harbors the DYT1 dystonia mutation. Synapse (2012) 0.88
Glutamatergic neurotransmission and protein kinase C play a role in neuron-glia communication during the development of methamphetamine-induced psychological dependence. Eur J Neurosci (2005) 0.86
Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization. J Neurochem (2005) 0.86
Real-time, spatially resolved analysis of serotonin transporter activity and regulation using the fluorescent substrate, ASP+. J Neurochem (2010) 0.86
Neurobiology of attention deficit/hyperactivity disorder. Pediatr Res (2011) 0.85
Effects of methylphenidate: the cellular point of view. Atten Defic Hyperact Disord (2010) 0.85
Dopamine transporter-dependent induction of C-Fos in HEK cells. Synapse (2002) 0.85
ADHDgene: a genetic database for attention deficit hyperactivity disorder. Nucleic Acids Res (2011) 0.85
Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter. Brain Res (2006) 0.84
Lateral diffusion and exocytosis of membrane proteins in cultured neurons assessed using fluorescence recovery and fluorescence-loss photobleaching. J Vis Exp (2012) 0.83
Methylphenidate exerts no neurotoxic, but neuroprotective effects in vitro. J Neural Transm (Vienna) (2006) 0.82
Effects of methylphenidate on the membrane potential and current in neurons of the rat locus coeruleus. J Neurophysiol (2002) 0.82
Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area. Life Sci (2005) 0.80
Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions. CNS Drugs (2009) 0.80
[Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guideline. Part 1: overview and recommendations]. Z Kinder Jugendpsychiatr Psychother (2008) 0.80
Lack of development of behavioral sensitization to methylphenidate in mice: correlation with reversible astrocytic activation. Eur J Pharmacol (2007) 0.80
Watching proteins in the wild: fluorescence methods to study protein dynamics in living cells. Traffic (2000) 0.79
Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: an in-vitro study in human neuronal and immune cells. J Psychopharmacol (2009) 0.79
Methylphenidate enhances inhibitory synaptic transmission by increasing the content of norepinephrine in the locus coeruleus of juvenile rats. Kurume Med J (2010) 0.78
Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine. Neuropsychopharmacology (2010) 0.78
Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein. Eur J Pharmacol (2007) 0.78
Dopamine and norepinephrine transporter-dependent c-Fos production in vitro: relevance to neuroadaptation. J Neurosci Methods (2005) 0.78
Dopaminergic ventral tegmental neurons modulated by methylphenidate. Life Sci (2004) 0.78
The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptor. Pharmazie (2009) 0.77
Like a rolling stone: the mobility of maerl (Corallinaceae) and the neutrality of the associated assemblages. Ecology (2009) 0.77
[Differences in neuronal toxicity and its molecular mechanisms between methamphetamine and methylphenidate]. Nihon Shinkei Seishin Yakurigaku Zasshi (2009) 0.75
Impact of psychostimulants and atomoxetine on the expression of 8-hydroxyguanine glycosylase 1 in human cells. J Neural Transm (Vienna) (2010) 0.75
Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 3.13
Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci (2009) 2.95
Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry (2012) 2.48
Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm (Vienna) (2008) 2.43
Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.86
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet (2011) 1.63
Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. J Neurosci (2008) 1.58
Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 1.48
The feedback-related negativity (FRN) revisited: new insights into the localization, meaning and network organization. Neuroimage (2013) 1.15
Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B Neuropsychiatr Genet (2013) 1.11
Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder. Psychopharmacology (Berl) (2006) 1.11
Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol (2005) 1.08
Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci (2007) 1.04
The extent of social anxiety in combination with mental disorders. Eur Child Adolesc Psychiatry (2006) 0.99
Vigilance and sustained attention in children and adults with ADHD. J Atten Disord (2008) 0.99
Novel mutations of the extraneuronal monoamine transporter gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol (2007) 0.96
Gene expression as peripheral biomarkers for sporadic Alzheimer's disease. J Alzheimers Dis (2009) 0.94
Prodynorphin storage and processing in axon terminals and dendrites. FASEB J (2006) 0.93
Prodynorphin transcripts and proteins differentially expressed and regulated in the adult human brain. FASEB J (2005) 0.92
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90
Brain dopamine and kinematics of graphomotor functions. Hum Mov Sci (2006) 0.89
Animal models of attention deficit/hyperactivity disorder (ADHD): a critical review. Atten Defic Hyperact Disord (2010) 0.89
Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study. J Psychiatr Res (2008) 0.89
Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder. J Neural Transm (Vienna) (2014) 0.85
First clinical trial of tomographic neurofeedback in attention-deficit/hyperactivity disorder: evaluation of voluntary cortical control. Clin Neurophysiol (2012) 0.85
Effects of methylphenidate: the cellular point of view. Atten Defic Hyperact Disord (2010) 0.85
Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease. J Alzheimers Dis (2007) 0.85
Potent neuroprotective effects of novel structural derivatives of valproic acid: potential roles of HDAC inhibition and HSP70 induction. Neurosci Lett (2010) 0.84
Well-being among persons at risk of psychosis: the role of self-labeling, shame, and stigma stress. Psychiatr Serv (2014) 0.83
Diabetes type II: a risk factor for depression-Parkinson-Alzheimer? Neurotox Res (2010) 0.83
Dysregulation of cell death machinery in the prefrontal cortex of human alcoholics. Int J Neuropsychopharmacol (2008) 0.82
The link between iron, metabolic syndrome, and Alzheimer's disease. J Neural Transm (Vienna) (2010) 0.82
Candidate system analysis in ADHD: evaluation of nine genes involved in dopaminergic neurotransmission identifies association with DRD1. World J Biol Psychiatry (2012) 0.81
5-HT2A serotonin receptor agonist DOI alleviates cytotoxicity in neuroblastoma cells: role of the ERK pathway. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.81
Familiality and molecular genetics of attention networks in ADHD. Am J Med Genet B Neuropsychiatr Genet (2010) 0.81
Attention and movement execution during handwriting. Hum Mov Sci (2006) 0.81
DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders. Neuropsychopharmacology (2011) 0.80
Altered mRNA expression of monoaminergic candidate genes in the blood of children with attention deficit hyperactivity disorder and autism spectrum disorder. World J Biol Psychiatry (2011) 0.80
[Children and adolescents with obsessive-compulsive disorders]. Z Kinder Jugendpsychiatr Psychother (2009) 0.80
Neuroimaging of cognitive brain function in paediatric obsessive compulsive disorder: a review of literature and preliminary meta-analysis. J Neural Transm (Vienna) (2012) 0.80
The neurobiological link between OCD and ADHD. Atten Defic Hyperact Disord (2014) 0.79
Attitudes towards help-seeking and stigma among young people at risk for psychosis. Psychiatry Res (2013) 0.79
KCNIP4 as a candidate gene for personality disorders and adult ADHD. Eur Neuropsychopharmacol (2012) 0.78
Reduced NoGo-anteriorisation during continuous performance test in deletion syndrome 22q11.2. J Psychiatr Res (2010) 0.78
Genotoxicity of the neurotransmitter dopamine in vitro. Toxicol In Vitro (2009) 0.78
No increased chromosomal damage in L-DOPA-treated patients with Parkinson's disease: a pilot study. J Neural Transm (Vienna) (2010) 0.78
Methyl- and acetyltransferases are stable epigenetic markers postmortem. Cell Tissue Bank (2010) 0.77
Detection of malingered attention deficit hyperactivity disorder. Atten Defic Hyperact Disord (2009) 0.77
[Severe early-childhood obsessive-compulsive disorder--case report on a 4-year-old girl]. Z Kinder Jugendpsychiatr Psychother (2006) 0.76
Brain-derived neurotrophic factor V66M polymorphism in childhood-onset obsessive-compulsive disorder. Int J Neuropsychopharmacol (2005) 0.76
Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer's disease. Curr Alzheimer Res (2013) 0.76
Transmission disequilibrium analysis of the functional 5-HT3A receptor variant C178T in early-onset obsessive compulsive-disorder. J Psychopharmacol (2007) 0.76
Frequency and correlates of DSM-5 attenuated psychosis syndrome in a sample of adolescent inpatients with nonpsychotic psychiatric disorders. J Clin Psychiatry (2015) 0.75
Tetrahydroisoquinoline derivatives: a new perspective on monoaminergic dysfunction in children with ADHD? Behav Brain Funct (2007) 0.75
[Validation of the German version of the Australian Scale of Asperger's Syndrome (ASAS)]. Z Kinder Jugendpsychiatr Psychother (2005) 0.75
[Psychometric properties and clinical norms for the German version (SPAIK) of the Social Phobia and Anxiety Inventory for Children (SPAI-C)]. Z Kinder Jugendpsychiatr Psychother (2011) 0.75
The effects of callous-unemotional traits and aggression subtypes on amygdala activity in response to negative faces - ERRATUM. Psychol Med (2020) 0.75
[Genetics of child and adolescent psychiatric disorders]. Z Kinder Jugendpsychiatr Psychother (2008) 0.75
To Andreas Warnke, Professor of Child and Adolescent Psychiatry, Head of the Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy at the University of Wuerzburg, Germany, to celebrate his professional life and work at the occasion of his 65th anniversary. Atten Defic Hyperact Disord (2010) 0.75
Pilot study: potential transcription markers for adult attention-deficit hyperactivity disorder in whole blood. Atten Defic Hyperact Disord (2012) 0.75
[Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)]. Psychiatr Pol (2009) 0.75
[Obsessive-compulsive disorder in children and adolescents]. Prax Kinderpsychol Kinderpsychiatr (2008) 0.75
Haplotype co-segregation with attention deficit-hyperactivity disorder in unrelated German multi-generation families. Am J Med Genet B Neuropsychiatr Genet (2013) 0.75
[In Process Citation]. Praxis (Bern 1994) (2013) 0.75
The effect of caffeine on handwriting movements in skilled writers. Hum Mov Sci (2006) 0.75
Extraordinarily fast response to low-dose sertraline in a child with severe obsessive-compulsive disorder and high functioning serotonin transporter genotype. J Child Adolesc Psychopharmacol (2014) 0.75